calcitonin gene-related peptide receptor — Drug Target
All drugs that target calcitonin gene-related peptide receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.
Drug classes
calcitonin gene-related peptide receptor antagonist · Calcitonin Gene-related Peptide Receptor Antagonist · Calcitonin gene-related peptide receptor antagonist
Marketed (7)
- Rimegepant 75mg every other day dosing · Pfizer · calcitonin gene-related peptide receptor antagonist · Neuroscience
Rimegepant targets the calcitonin gene-related peptide receptor to treat migraines. - Aimovig · Amgen · Neuroscience
Aimovig works by blocking the calcitonin-gene-related peptide receptor, a protein involved in migraine pain. - Nurtec Odt · Pfizer · Calcitonin Gene-related Peptide Receptor Antagonist · Neuroscience
Rimegepant blocks the calcitonin gene-related peptide receptor. - Rimegepant 75mg daily dosing · Pfizer · calcitonin gene-related peptide receptor antagonist · Neuroscience
Rimegepant is a calcitonin gene-related peptide receptor antagonist that inhibits the release of pro-inflammatory peptides. - Rimegepant 25 MG · Pfizer · calcitonin gene-related peptide receptor antagonist · Neuroscience
- Rimegepant for acute migraine treatment · Pfizer · calcitonin gene-related peptide receptor antagonist · Neuroscience
Rimegepant targets the calcitonin gene-related peptide receptor to treat acute migraine. - Rimegepant 75mg Orally Disintegrating Tablets (ODT) · Pfizer · calcitonin gene-related peptide receptor antagonist · Neuroscience
Rimegepant is a calcitonin gene-related peptide receptor antagonist.
Phase 3 pipeline (1)
- Placebo-matching Ubrogepant · Allergan · Calcitonin gene-related peptide receptor antagonist · Neurology
Ubrogepant is a calcitonin gene-related peptide receptor antagonist.
Phase 2 pipeline (1)
- BHV-8000 · Biohaven Therapeutics Ltd. · Calcitonin gene-related peptide receptor antagonist · Neurology
BHV-8000 is a calcitonin gene-related peptide receptor antagonist.